These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3490992)

  • 1. Protective effect of partially purified human urinary colony-stimulating factor on granulocytopenia after antitumor chemotherapy.
    Motoyoshi K; Takaku F; Maekawa T; Miura Y; Kimura K; Furusawa S; Hattori M; Nomura T; Mizoguchi H; Ogawa M
    Exp Hematol; 1986 Dec; 14(11):1069-75. PubMed ID: 3490992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of partially purified human urinary colony-stimulating factor.
    Motoyoshi K; Ishizaka Y; Miura Y; Takaku F
    Immunobiology; 1986 Sep; 172(3-5):205-12. PubMed ID: 3492430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trial of CSF-HU (colony-stimulating factor derived from human urine: P-100) on granulocytopenia induced by anticancer therapy in urogenital cancer patients].
    Matsumoto K; Kakizoe T; Nakagami Y; Rin S; Ito H; Koyanagi T; Sakashita S; Nagayama T; Miyauchi T; Toyoshima A
    Hinyokika Kiyo; 1987 Jun; 33(6):972-82. PubMed ID: 3499770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study on the effect of CSF-HU (colony stimulating factor human urine) on leukopenia and granulocytopenia induced by cancer chemotherapy--a double-blind study in patients with genito-urinary cancer].
    Niijima T; Aso Y; Akaza H; Kawai T; Matsumoto K; Tachibana M; Nishio Y; Kotake T; Takaku F; Matsumura Y
    Hinyokika Kiyo; 1988 Aug; 34(8):1483-92. PubMed ID: 3057832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colony-stimulating factors in cancer chemo- and radiotherapy].
    Okabe T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):810-9. PubMed ID: 2455481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH; Schulman KA; Buckner CD
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of human urinary colony stimulating factor after bone marrow transplantation.
    Masaoka T; Motoyoshi K; Takaku F; Kato S; Harada M; Kodera Y; Kanamaru A; Moriyama Y; Ohno R; Ohira M
    Bone Marrow Transplant; 1988 Mar; 3(2):121-7. PubMed ID: 3048476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of human urinary colony-stimulating factor.
    Ishizaka Y; Motoyoshi K; Hatake K; Saito M; Takaku F; Miura Y
    Exp Hematol; 1986 Jan; 14(1):1-8. PubMed ID: 3484706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human granulocyte colony stimulating factor on granulocytopenia induced by cytotoxic chemotherapy in patients with multiple myeloma.
    Pogłód R; Kraj M; Maj S
    Mater Med Pol; 1995; 27(3):83-9. PubMed ID: 8935143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcoma.
    Dinçol D; Samur M; Pamir A; Sencan O; Akbulut H; Yalçin B; Onur H; Demirkazik A; Senler FC; Içli F
    Cancer; 2000 May; 88(9):2033-6. PubMed ID: 10813713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Colony stimulating factors in chemotherapy induced neutropenic fever].
    Sanz Rubiales A; García Alvarez G; Centeno Cortés C; Martín Ortega Y; Del Valle Rivero AL; Nieto Sanz J
    An Med Interna; 1998 Feb; 15(2):100-4. PubMed ID: 9542208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF and the management of clozapine-induced agranulocytosis.
    Gerson SL
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood stem cell mobilization with chemotherapy and granulocyte-colony stimulating factor in patients with hematological malignancies.
    Watanabe S; Mukaiyama T; Ogawa Y; Kawada H; Ichikawa Y
    Tokai J Exp Clin Med; 1994 Dec; 19(3-6):143-55. PubMed ID: 7570686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The beneficial effect of human urinary colony-stimulating factor (P-100) on recovery from granulocytopenia after anti-cancer chemotherapy for gynecologic cancer].
    Kasamatsu T; Tsunematsu R; Ueda K; Miyagawa N; Kawana T; Kawagoe K; Takizawa K; Takaku F; Mizuno M; Yoshikawa H
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1551-9. PubMed ID: 3053944
    [No Abstract]   [Full Text] [Related]  

  • 19. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
    Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.